- Home
- DHF
as 07-26-2024 4:00pm EST
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 176.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 451.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $2.06 - $2.39 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BNY Mellon High Yield Strategies Fund News
DHF Breaking Stock News: Dive into DHF Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
BNY Mellon High Yield Strategies Fund Declares Dividend
Business Wire
a month ago
BNY Mellon High Yield Strategies Fund Declares Dividend
Business Wire
2 months ago
BNY Mellon High Yield Strategies Fund Declares Dividend
Business Wire
3 months ago
BNY Mellon High Yield Strategies Fund Declares Dividend
Business Wire
4 months ago
BNY Mellon High Yield Strategies Fund Declares Dividend
Business Wire
5 months ago
BNY Mellon High Yield Strategies Fund Declares Distribution and Announces Increase in Monthly Distribution Amount
Business Wire
6 months ago
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
GlobeNewswire
6 months ago
Ponce De Leon Foundation Announces Grant Awards
Compare DHF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DHF BNY Mellon High Yield Strategies Fund - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.